Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility

Landi, M.T.; Bishop, D.T.; MacGregor, S.; Machiela, M.J.; Stratigos, A.J.; Ghiorzo, P.; ... ; MelaNostrum Consortium (2020)

Article / Letter to editor

Meta-analysis of 36,760 cases and 375,188 controls identifies 54 loci associated with susceptibility to cutaneous melanoma. Further analysis combining nevus count and hair color GWAS results provide insights into the genetic architecture of melanoma.Most genetic susceptibility to cutaneous melanoma remains to be discovered. Meta-analysis genome-wide association study (GWAS) of 36,760 cases of melanoma (67% newly genotyped) and 375,188 controls identified 54 significant (P < 5 x 10(-8)) loci with 68 independent single nucleotide polymorphisms. Analysis of risk estimates across geographical regions and host factors suggests the acral melanoma subtype is uniquely unrelated to pigmentation. Combining this meta-analysis with GWAS of nevus count and hair color, and transcriptome association approaches, uncovered 31 potential secondary loci for a total of 85 cutaneous melanoma susceptibility loci. These findings provide insights into cutaneous melanoma genetic architecture, reinforcing the importance of nevogenesis, pigmentation and telomere maintenance, together with identifying potential new pathways for cutaneous melanoma pathogenesis.

• All authors: Landi, M.T.; Bishop, D.T.; MacGregor, S.; Machiela, M.J.; Stratigos, A.J.; Ghiorzo, P.; Brossard, M.; Calista, D.; Choi, J.; Fargnoli, M.C.; Zhang, T.W.; Rodolfo, M.; Trower, A.J.; Menin, C.; Martinez, J.; Hadjisavvas, A.; Song, L.; Stefanaki, I.; Scolyer, R.; Yang, R.; Goldstein, A.M.; Potrony, M.; Kypreou, K.P.; Pastorino, L.; Queirolo, P.; Pellegrini, C.; Cattaneo, L.; Zawistowski, M.; Gimenez-Xavier, P.; Rodriguez, A.; Elefanti, L.; Manoukian, S.; Rivoltini, L.; Smith, B.H.; Loizidou, M.A.; Regno, L. del; Massi, D.; Mandala, M.; Khosrotehrani, K.; Akslen, L.A.; Amos, C.I.; Andresen, P.A.; Avril, M.F.; Azizi, E.; Soyer, H.P.; Bataille, V.; Dalmasso, B.; Bowdler, L.M.; Burdon, K.P.; Chen, W.V.; Codd, V.; Craig, J.E.; Debniak, T.; Falchi, M.; Fang, S.; Friedman, E.; Simi, S.; Galan, P.; Garcia-Casado, Z.; Gillanders, E.M.; Gordon, S.; Green, A.; Gruis, N.A.; Hansson, J.; Harland, M.; Harris, J.; Helsing, P.; Henders, A.; Hocevar, M.; Hoiom, V.; Hunter, D.; Ingvar, C.; Kumar, R.; Lang, J.; Lathrop, G.M.; Lee, J.E.; Li, X.; Lubinski, J.; Mackie, R.M.; Malt, M.; Malvehy, J.; McAloney, K.; Mohamdi, H.; Molven, A.; Moses, E.K.; Neale, R.E.; Novakovic, S.; Nyholt, D.R.; Olsson, H.; Orr, N.; Fritsche, L.G.; Puig-Butille, J.A.; Qureshi, A.A.; Radford-Smith, G.L.; Randerson-Moor, J.; Requena, C.; Rowe, C.; Samani, N.J.; Sanna, M.; Schadendorf, D.; Schulze, H.J.; Simms, L.A.; Smithers, M.; Song, F.; Swerdlow, A.J.; Stoep, N. van der; Kukutsch, N.A.; Visconti, A.; Wallace, L.; Ward, S.V.; Wheeler, L.; Sturm, R.A.; Hutchinson, A.; Jones, K.; Malasky, M.; Vogt, A.; Zhou, W.; Pooley, K.A.; Elder, D.E.; Han, J.L.; Hicks, B.; Hayward, N.K.; Kanetsky, P.A.; Brummett, C.; Montgomery, G.W.; Olsen, C.M.; Hayward, C.; Dunning, A.M.; Martin, N.G.; Evangelou, E.; Mann, G.J.; Long, G.; Pharoah, P.D.P.; Easton, D.F.; Barrett, J.H.; Cust, A.E.; Abecasis, G.; Duffy, D.L.; Whiteman, D.C.; Gogas, H.; Nicolo, A. de; Tucker, M.A.; Newton-Bishop, J.A.; Peris, K.; Chanock, S.J.; Demenais, F.; Brown, K.M.; Puig, S.; Nagore, E.; Shi, J.X.; Iles, M.M.; Law, M.H.; GenoMEL Consortium; Q-MEGA Investigator; QTWIN Investigator; ATHENS Melanoma Study Grp; 23andMe; SDH Study Grp; IBD Investigators; Essen-Heidelberg Investigators; AMFS Investigators; MelaNostrum Consortium
• Date: 2020-04-27
• Journal: Nature Genetics
• Volume: 52
• Issue: 5
• Pages: 494 - 504
• DOI: doi:10.1038/s41588-020-0611-8
• Link: https://www.nature.com/articles/s41588-020-0611-8